Company / Tangible Book Value per Share
CRESCENT BIOPHARMA, INC. Tangible Book Value per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Tangible Book Value per Share
$199.30
FY2025
5-year range
$0.15 / $199.30
FY2021-FY2025
Trend
+11349.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Tangible Book Value per Share changed +11350% YoY in FY2025, a notable deviation from the 4-year average annual change of +3213%.
Based on SEC 10-K filings.
199.30 in FY2025 with a 10-year CAGR of +104.8%.
Improved from $2.67 to $199.30 over the past 9 years.
Tangible Book Value per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- +104.8%
Key checks
Key Insights
- In FY2025, tangible book value per share increased 11349.6% year-over-year.
- Lowest tangible book value per share in the period was in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.35 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Tangible Book Value per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $199.30 | +11349.6% |
| FY2017 | $1.74 | -34.7% |
| FY2016 | $2.67 | +1637.2% |
| FY2015 | $0.15 | -98.3% |
| FY2014 | $8.78 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026